Publication:
Consumption of Ultra-Processed Food and Drinks and Chronic Lymphocytic Leukemia in the MCC-Spain Study

dc.contributor.authorSolans, Marta
dc.contributor.authorFernández-Barrés, Sílvia
dc.contributor.authorRomaguera, Dora
dc.contributor.authorBenavente, Yolanda
dc.contributor.authorMarcos-Gragera, Rafael
dc.contributor.authorGràcia-Lavedan, Esther
dc.contributor.authorCostas, Laura
dc.contributor.authorRobles, Claudia
dc.contributor.authorGonzalez-Barca, Eva
dc.contributor.authorde la Banda, Esmeralda
dc.contributor.authorAlonso, Esther
dc.contributor.authorAymerich, Marta
dc.contributor.authorCampo, Elias
dc.contributor.authorLlorca, Javier
dc.contributor.authorFernández-Tardón, Guillermo
dc.contributor.authorOlmedo-Requena, Rocío
dc.contributor.authorGimeno, Eva
dc.contributor.authorCastaño-Vinyals, Gemma
dc.contributor.authorAragones, Nuria
dc.contributor.authorKogevinas, Manolis
dc.contributor.authorPollan-Santamaria, Marina
dc.contributor.authorde Sanjose, Silvia
dc.contributor.authorAmiano, Pilar
dc.contributor.authorCasabonne, Delphine
dc.contributor.funderMinisterio de Economía y Competitividad (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERESP (Epidemiología y Salud Pública)
dc.contributor.funderAgència de Gestió d´Ajuts Universitaris i de Recerca (AGAUR)
dc.contributor.funderInstitució Catalana de Recerca i Estudis Avançats
dc.date.accessioned2022-03-29T09:13:54Z
dc.date.available2022-03-29T09:13:54Z
dc.date.issued2021-05-20
dc.description.abstractChronic lymphocytic leukemia (CLL) is the most common leukemia in adults in Western countries. Its etiology is largely unknown but increasing incidence rates observed worldwide suggest that lifestyle and environmental factors such as diet might play a role in the development of CLL. Hence, we hypothesized that the consumption of ultra-processed food and drinks (UPF) might be associated with CLL. Data from a Spanish population-based case-control study (MCC-Spain study) including 230 CLL cases (recruited within three years of diagnosis) and 1634 population-based controls were used. The usual diet during the previous year was collected through a validated food frequency questionnaire and food and drink consumption was categorized using the NOVA classification scheme. Logistic regression models adjusted for potential confounders were used. Overall, no association was reported between the consumption of UPF and CLL cases (OR per each 10% increase of the relative contribution of UPF to total dietary intake = 1.09 (95% CI: 0.94; 1.25)), independently of the Rai stage at diagnosis. However, when analyses were restricted to cases diagnosed within <1 year (incident), each 10% increment in the consumption of UPF was associated with a 22% higher odds ratio of CLL (95% CI: 1.02, 1.47) suggesting that the overall results might be affected by the inclusion of prevalent cases, who might have changed their dietary habits after cancer diagnosis. Given the low number of cases in the subgroup analyses and multiple tests performed, chance findings cannot totally be ruled out. Nonetheless, positive associations found in CLL incident cases merit further research, ideally in well-powered studies with a prospective design.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis research was funded by the Spanish Ministry of Economy and Competitiveness Carlos III Institute of Health co-funded by FEDER funds/European Regional Development Fund (ERDF), a way to build Europe (grants PI17/01280, PI11/01810, PI14/01219, PI11/02213, PI09/1662, PI15/00966, PI18/00909, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056, Rio Hortega CM13/00232, Juan de la Cierva de Incorporacion IJCI-2016-29502 and SV-09-CLINIC-1), Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP, Spain) and Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), CERCA Programme/Generalitat de Catalunya for institutional support(2017SGR1085) and European Regional Development FundERDF/FEDER. The ICGC CLL-Genome Project was funded by the Spanish Ministerio de Economía y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII), PMP15/00007, which is part of Plan Nacional de I+D+I and is co-financed by the ISCIII-Sub-Directorate General for Evaluation and the European Regional Development Fund (FEDER-”Una manera de Hacer Europa”) and CIBERONC. We acknowledge support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S) and support from the Generalitat de Catalunya through the CERCA Program. The funders had no role in the design and conduct of the study; collection, analysis and interpretation of the data and the preparation, review or approval of the manuscript.es_ES
dc.format.number10es_ES
dc.format.volume18es_ES
dc.identifier.citationInt J Environ Res Public Health. 2021 May 20;18(10):5457.es_ES
dc.identifier.doi10.3390/ijerph18105457es_ES
dc.identifier.e-issn1660-4601es_ES
dc.identifier.journalInternational Journal of Environmental Research and Public Healthes_ES
dc.identifier.otherhttps://hdl.handle.net/20.500.13003/19513
dc.identifier.pubmedID34065213es_ES
dc.identifier.puiL2007238563
dc.identifier.scopus2-s2.0-85106031676
dc.identifier.urihttp://hdl.handle.net/20.500.12105/13873
dc.identifier.wos654961900001
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MSC//RD06%2F0020%2F0095/ES/RED TEMÁTICA DE INVESTIGACIÓN COOPERATIVA DEL CANCER/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//RD12%2F0036%2F0056/ES/Cáncer/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RCESP C03/09es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RTICESP C03/10es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CM13/00232es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/IJCI-2016-29502es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SV-09-CLINIC-1es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/MINECO//PMP15%2F00007/ES/Functional and Clinical Impact of Genomic Analysis in CLL/es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CEX2018-000806-Ses_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI17/01280es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI11/01810es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI14/01219es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI11/02213es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI09/1662es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI15/00966es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI18/00909es_ES
dc.relation.publisherversionhttps://doi.org/10.3390/ijerph18105457es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectNOVA classificationes_ES
dc.subjectCanceres_ES
dc.subjectCase-control studyes_ES
dc.subjectChronic lymphocytic leukemiaes_ES
dc.subjectUltra-processed foodes_ES
dc.subject.decsManipulación de Alimentos
dc.subject.decsComida Rápida
dc.subject.decsHumanos
dc.subject.decsEstudios Prospectivos
dc.subject.decsAdulto
dc.subject.decsDieta
dc.subject.decsLeucemia Linfocótica Crónica de Células B
dc.subject.decsEstudios de Casos y Controles
dc.subject.decsEspaña
dc.subject.meshDiet
dc.subject.meshCase-Control Studies
dc.subject.meshProspective Studies
dc.subject.meshSpain
dc.subject.meshAdult
dc.subject.meshFood Handling
dc.subject.meshHumans
dc.subject.meshFast Foods
dc.subject.meshLeukemia, Lymphocytic, Chronic, B-Cell
dc.titleConsumption of Ultra-Processed Food and Drinks and Chronic Lymphocytic Leukemia in the MCC-Spain Studyes_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication57cdf9f1-5836-41aa-9880-cf773b0e65f9
relation.isAuthorOfPublicationbdb2687b-1299-4a83-9603-d7d83ab19b62
relation.isAuthorOfPublicationcb3b77d8-c78c-4238-9b9d-c1171ff3ab51
relation.isAuthorOfPublication.latestForDiscovery57cdf9f1-5836-41aa-9880-cf773b0e65f9
relation.isFunderOfPublication77b2fc20-6311-4e46-98a7-83e46257b93b
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublication4732254a-afa9-4d9b-8756-8745a4b43003
relation.isFunderOfPublicationaf365449-d1bb-4678-af42-7483b561cd83
relation.isFunderOfPublication597d8a00-f8e8-45dd-b797-5ecfd2271de6
relation.isFunderOfPublication.latestForDiscovery77b2fc20-6311-4e46-98a7-83e46257b93b
relation.isPublisherOfPublication30293a55-0e53-431f-ae8c-14ab01127be9
relation.isPublisherOfPublication.latestForDiscovery30293a55-0e53-431f-ae8c-14ab01127be9

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
ConsumptionOfUltraProcessed_2021.pdf
Size:
548.15 KB
Format:
Adobe Portable Document Format
Description:
Artículo principal
Loading...
Thumbnail Image
Name:
ConsumptionOfUltraProcessedSupplementaryMaterials_2021.pdf
Size:
660.39 KB
Format:
Adobe Portable Document Format
Description:
Supplementary data